SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37592872.
- Also identified by DOI 10.1093/infdis/jiad353.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three and a half years into the coronavirus disease 2019 (COVID-19) pandemic, the nature and durability of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still remains unclear. Current COVID-19 mRNA vaccines have been shown to provide minimal protection against infection with XBB variants but substantial protection against severe disease. However, such protection appears to wane quickly. In contrast, protection from the combination of both vaccination and infection, termed "hybrid immunity", has been shown to be greater in magnitude and durability than that provided by either vaccine immunity or natural immunity alone.
Medical subject headings
- SARS-CoV-2
- COVID-19